News & Updates
Event Calendar
June 17, 2013 - 4:00pm
June 22, 2013 (All day)
Find A Specialist
Resource Finder at Kennedy Krieger Institute
Submitted by admin on June 23, 2011 - 3:08pm
A free resource that provides access to information and support for individuals and families living with developmental disabilities.

Laurie Blitz began to suspect that something was not quite right with her daughter as early as when she was a toddler. Erin seemed overly hyperactive, moving so much that even simple tasks like changing her diaper became lessons in patience and control. When she was old enough to walk, she would constantly run away, placing herself in danger.
Ask a young child what the toughest subject is in school, and he is likely to say math or reading. While there have been thousands of studies on reading disabilities and, consequently, methods developed for overcoming them there have been far fewer on math dysfunction. Michèle M. M.
Every morning, 3-year-old La'Nell Alewine and her 4-year-old sister, Ja'Nell, get dressed and make their way to preschool at the Dayspring Head Start Center in East Baltimore. There, the girls eat a healthy breakfast, play with their classmates and learn about the alphabet, colors and numbers.
If you've ever doubted how quickly your life can be turned upside down, just ask the Bahen family. On Monday, Nov. 14, 2000, the Bahens' 5-year-old daughter Nicole joined her friends for her usual afternoon dance class. By Sunday Nov. 20, Nicole lay in intensive care recovering from surgery, unable to speak, roll over or swallow, nearly paralyzed on her right side. Such is the swift devastation of a pediatric brain tumor.
Researchers at Kennedy Krieger Institute are investigating two experimental treatments that it is hoped will slow or stop the progress of Alzheimer's disease in people with
Since the late Dr. Andreas Rett first identified the syndrome that bears his name more than 50 years ago, doctors have learned to treat the seizures, reflux and other symptoms of the disorder but they have not yet learned to alleviate the neurological impairment it causes. Researchers at Kennedy Krieger will begin a new drug trial this summer that represents an important step toward achieving that goal.